Peer Exchange


Epilepsy: Current Trends and Treatments for Focal Seizures

A panel of experts elucidate updated information regarding the incidence and causes of epilepsy that may lead to better, more accurate management.

A comprehensive review of the classification of seizure types by the ILAE in 2017 and how that has improved patient categorization.

Expert panelists share insight on the tools used to make an informed diagnosis of epilepsy and discuss genetic testing in adult versus younger groups.

Individualized goals of therapy for patients with epilepsy are outlined with regard to age, demographic, and safety/efficacy in treatment.

Given previously unmet needs in diagnostic/prognostic biomarkers for epilepsy, experts consider how genetic markers and imaging might improve treatment.

With considerations for specific patient cases, the panel debates when the optimal time to initiate therapy for epilepsy would be.

Further taking into account patient demographics and disease factors, the panel reflects on treatment initiation thresholds for epilepsy.

The panel of experts considers how there are individualized limitations in using otherwise helpful clinical guidelines to manage patients with epilepsy.

In light of the ever-expanding armamentarium of agents to manage epilepsy, experts elucidate differences amid older and newer medications.

A comprehensive outline of factors that can inform the selection of therapy for patients with epilepsy given approved agents.

An elucidation of available extended release formula therapy and the optimal selection and administration of these agents.

Experts consider the importance of adherence in treating epilepsy and reflect on what might contribute to nonadherence in specific patients.

The panel sheds light on best approaches to discontinuing therapy, if appropriate, in epilepsy management.

Given the transition from pediatric to adult care in the case of epilepsy, experts consider who and what needs to be involved to optimize the process.

Experts explore the nonmedication paradigm in epilepsy management with regard to surgical and lifestyle-modification approaches.

Homing in on stimulation approaches to treating epilepsy, the panel considers the respective and comparative value of these approaches.

The expert panelists share prominent take-home messages and discuss where they believe the field of epilepsy management will head in upcoming years.

In light of the current epilepsy treatment landscape, an expert neurologist breaks down the rationale behind the pharmacologics in this setting.

Key opinion leader Rodney A. Radtke, MD, explains the benefit of using extended-release formulations to treat patients with epilepsy.

Given challenges with adherence and transition of care in epilepsy, an expert explains how to optimally follow patients to avoid complication.

The epilepsy expert considers challenges inherent in managing epileptic encephalopathies and outlines emerging treatment options.

A comprehensive review of cannabidiol’s potential role in improving care for patients with epileptic encephalopathies.

Key opinion leader Rodney A. Radtke, MD, shares parting advice with neurologists regarding the treatment of epilepsy and epileptic encephalopathies.
SAP Partner Banner